StockData
Aktis Oncology, Inc. logo

Aktis Oncology, Inc. (AKTS) stock

AKTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$16.10−0.21 (-1.29%)

Close on Nov 18, 2026Market cap $895.47MP/E –Yield –

Aktis Oncology market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Aktis Oncology's market cap was $910.72M on Nov 11, 2026.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$910.72M–

More Aktis Oncology figures

See a number that looks wrong?